Understanding and improving the quality of primary care for people in prison: a mixed-methods study

Bellass S, Canvin K, Farragher T, McLintock K, Wright N, Hearty P, Seanor N, Cunningham M, Foy R, Sheard L
Record ID 32018013550
English
Authors' objectives: People in prison are generally in poorer health than their peers in the community, often living with chronic illness and multimorbidity. Healthcare research in prisons has largely focused on specific problems, such as substance use; less attention has been paid to conditions routinely managed in primary care, such as diabetes or hypertension. It is important to understand how primary care in prisons is currently delivered in the United Kingdom and how it can be improved, in order to reduce health inequalities. To understand the quality of primary care in prison, including gaps and variations in care, in order to recommend how quality of prison health care can be improved. Compared to community populations, people in prison have significantly poorer health, with higher levels of long-term conditions, disability, and premature death. They need and are entitled to appropriate health care. Most research on prison health care has previously focused on specific priorities, such as mental illness, blood-borne virus infections and substance misuse. However, less attention has been paid to the quality of ‘routine’ primary care. This is important given shifting demographics, including an ageing population with more long-term conditions, and the opportunities to improve outcomes through primary and secondary prevention. We examined the quality of primary care in prison and identified strategies for improvement. To identify quality indicators based on current national guidance which can be assessed using routinely collected data through a stakeholder panel. To explore perceptions of quality of care, including barriers to and enablers of recommended care and quality indicators, through qualitative interviews involving people who had been in prison and prison healthcare staff. To assess the quality of primary care provided to people in prison through analysis of anonymised and routinely held prison healthcare records. To integrate the above findings and identify quality-improvement interventions which can be monitored by our set of quality indicators. To understand quality of prison health care in relation to mental health needs.
Authors' results and conclusions: Marked variations in the quality of primary care in prisons are likely to be attributable to the local organisation and conditions of care delivery. Routinely collected data may offer a credible driver for change. We looked across all WPs to derive five headline ideas of interest regarding what we have learnt about the quality of prison health care from this mixed-methods programme of research. First, measurement and monitoring is the foundation of high-quality healthcare provision. While the Quality Outcomes Framework provides incentives for this in community primary care, the absence of any comparable lever in the prison setting leads to inconsistent quality of clinical coding. Second, there are marked variations in the quality of health care delivered between different prisons that are poorly explained by differences in prison population characteristics. People in prison highlighted variations when trying to access prison health care; these were often largely dependent on factors extraneous to the healthcare department itself. Third, we found no consistent signals from both the qualitative and quantitative work that any specific group related to age, gender or ethnicity were receiving better or worse care than others. Rather, for some female-specific and older age-specific indicators, the notable variation in quality was between the community and prison setting, with achievement being higher in the community. Fourth, factors at the level of the prison as an organisation and the prison system as an institution are likely to exhibit a large influence on quality of health care. Our qualitative findings pointed to understaffing as an umbrella issue which then has consequences for many aspects of day-to-day care delivery. Fifth, the prison–community interface is important when considering the high rate of recidivism in the UK prison population. This particularly relates to the limited interoperability between community and prison clinical systems and resulting losses in informational continuity which then contribute to deficits in health care. Implications for health care and recommendations for future research We highlight three implications for health care. First, the loss of informational continuity between community and prison primary care undermines individual patient care as well as the ability to measure and improve whole-system care. Improved linkage of individual electronic health records at this interface may deliver benefits for patient care and system-level improvement. Second, our work has demonstrated marked gaps and variations in achievement of quality indicators across 13 prisons served by one primary care provider which are incompletely explained by population characteristics. Such gaps and variations are likely to be a more widespread phenomenon affecting other prisons and warrant attention. Third, our suite of indicators, based on routinely collected data, may serve as a foundation for an efficient and evidence-based audit and feedback intervention, which could be scaled up and applied across the prison sector. We highlight two areas for future research: understanding ethnic variations in receipt of recommended health care; and evaluating the effectiveness and cost-effectiveness of strategies to improve primary care in prisons.
Authors' methods: A mixed-methods study with six interlinked work packages. Predominantly the North of England. Between August 2019 and June 2022, we undertook the following work packages: (1) International scoping review of prison healthcare quality indicators. (2) Stakeholder consensus process to identify United Kingdom focused prison healthcare quality indicators. (3) Qualitative interview study with 21 people who had been in prison and 22 prison healthcare staff. (4) Quantitative analysis of anonymised, routinely collected data derived from prison healthcare records (~ 25,000 records across 13 prisons). (5) Stakeholder deliberation process to identify interventions to improve prison health care. (6a) Secondary analysis of the qualitative data set, focusing on mental health and (6b) analysis of the quantitative data set, focusing on health care of three mental health subgroups Our analyses of indicator achievement were limited by the quality and coverage of available data. Most study findings are localised to England so international applicability may differ. Our mixed-methods programme had interlinked work packages (WPs) closely aligned to our objectives. It ran from August 2019 to July 2022 with research fieldwork and analyses over November 2019 to May 2022. Identification of quality indicators (WP1) Scoping review Methods We first conducted an international scoping review to describe existing literature on the development and selection of quality indicators for primary health care in the prison setting. We searched for articles published in English between 2004 and 2021. Our broad inclusion criteria included any research method, any health condition, and any country. We excluded papers relating to community criminal justice settings and on transitions from prison to community. We searched six electronic databases (MEDLINE, CINAHL, Scopus, EMBASE, PsycInfo and Criminal Justice Abstracts) supplemented by hand searching of four key journals, key author searches and forwards and backwards citation tracking. We performed a qualitative synthesis of eligible papers. A four-stage, iterative process involved (1) identification and screening of candidate indicators from guidance and wider literature, (2) shortlisting and selection with a stakeholder consensus panel, (3) reviewing and refining and (4) specifying eligible populations and criteria for achieving each indicator while piloting data extraction. This work took place from December 2019 to July 2020. We initially developed a ‘long-list’ of 361 candidate indicators derived from a range of sources including the National Institute for Health and Care Excellence, the Quality Outcomes Framework and local commissioning groups. Clinical research team members screened the list and agreed a reduction to 76 candidate indicators based on relevance to primary care, measurability and potential for patient benefit. Eight stakeholders with backgrounds in criminal justice, health care and mental health participated in the consensus process (face-to-face and online). They initially and independently rated each candidate indicator as having low, medium or high potential for significant patient benefit before a panel discussion and re-rating. We discarded all of the lowest-rated indicators and most of the medium-rated indicators. We then reviewed and specified the remaining 36 indicators, removing those that could not be reliably measured using routinely collected data and disaggregating selected composite (combined) indicators. We finally further defined and piloted indicators, producing a list of 30 indicators that spanned communicable disease, drug misuse, mental health, long-term conditions, prevention and screening. We interviewed 21 people who had been in prison and 22 healthcare staff. Participants were recruited through a variety of means but most often through patient and public involvement (PPI) partners (for people in prison) and through healthcare providers (for staff). We spoke to both men and women who had been in a range of different prisons; six were from an ethnic minority. Staff spanned a variety of healthcare roles and worked in both the male and female estate. All but two of the interviews were conducted over phone or video due to the COVID-19 pandemic. Interviews were on average about 40 minutes long and were conducted between November 2019 and March 2021. Analysis was undertaken by mapping the data onto a four-level quality-improvement matrix covering individual, team, organisation and wider system levels. We conducted repeated cross-sectional analyses of anonymised routinely collected electronic primary care data from 13 prisons in the North of England. We remotely extracted all data between April and November 2020. We measured achievement against 30 quality indicators over a 3-year period (April 2017–March 2020). We explored associations between achievement and individual and prison characteristics. Explanatory variables included prison category, age, gender, ethnicity and length of stay. Date-range searches for most indicators coincided with the Quality Outcomes Framework years (1 April–31 March) to allow indirect comparisons with the community for similar indicators. Descriptive statistics for each indicator were produced by year for each of the explanatory variables. We developed multilevel logistic regression models for each indicator to explore associations with achievement. We held three sequential online stakeholder workshops (October and November 2021, January 2022). Stakeholders were predominantly commissioners or deliverers of prison health care. In the first workshop, 28 stakeholders were presented with an integration of the findings of all prior WPs, which generated a broad discussion about the challenges of prison health care. Delegates were particularly interested in issues pertaining to opioid prescribing and women’s health. This first workshop also dovetailed as a dissemination event. In the second workshop, 10 stakeholders rated the importance of indicators after hearing about the evidence base for the likely success of differing implementation interventions. Delegates queried specifics regarding certain indicators and brought up interesting points about the prison healthcare tendering process and the potential for using routine data. In the third workshop, three stakeholders participated in a deliberation process using the APEASE criteria, and gave their opinions on the applicability of six candidate implementation strategies put forward by the research team, for example, audit and feedback. Following the deliberation process, we devised two illustrative improvement strategies for two indicators: opioid and gabapentinoid prescribing; and management of hypertension. Qualitative: We undertook a secondary analysis of the interview data set generated in WP2, comprising 43 interviews with prison leavers and prison healthcare staff. Seven of these interviews did not contain content about mental health and therefore this focused mental health analysis is based on 36 interviews. Reflexive thematic analysis was conducted. Quantitative: We re-analysed data from WP3, focusing on achievement and associations for three groups: people with no coded mental illness; people with a coded mental illness prescribed an antipsychotic drug in the previous 12 months; and people with a coded mental health diagnosis not prescribed an antipsychotic drug in the previous 12 months. We explored associations between indicator achievement and mental health groupings using multilevel logistic regression models.
Details
Project Status: Completed
Year Published: 2024
URL for additional information: English
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: United Kingdom
MeSH Terms
  • Primary Health Care
  • Prisons
  • Delivery of Health Care
  • Health Services for Prisoners
  • Public Health
Contact
Organisation Name: NIHR Health and Social Care Delivery Program
Contact Name: Rhiannon Miller
Contact Email: rhiannon.m@prepress-projects.co.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.